Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Depreciation & Amortization

$127.60M

TTM · Period ending: Jun 30, 2026 · USD

BIO Depreciation & Amortization

Latest reported$127.60Mperiod endingJun 30, 2026

BIO TTM Depreciation & Amortization ($10.30M → $127.60M)

TTM Depreciation & Amortization

High-resolution chart · PNG

BIO depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period ending	Depreciation & Amortization (USD)
Jun 30, 2026	127,600,000
Mar 31, 2026	168,200,000
Dec 31, 2025	165,400,000
Sep 30, 2025	172,200,000
Jun 30, 2025	166,900,000
Mar 31, 2025	162,700,000
Dec 31, 2024	161,700,000
Sep 30, 2024	149,600,000
Jun 30, 2024	148,000,000
Mar 31, 2024	147,400,000
Dec 31, 2023	145,900,000
Sep 30, 2023	148,700,000
Jun 30, 2023	145,700,000
Mar 31, 2023	144,000,000
Dec 31, 2022	141,800,000
Sep 30, 2022	135,500,000
Jun 30, 2022	134,900,000
Mar 31, 2022	134,500,000
Dec 31, 2021	133,800,000
Sep 30, 2021	136,300,000
Jun 30, 2021	136,200,000
Mar 31, 2021	137,200,000
Dec 31, 2020	138,100,000
Sep 30, 2020	105,200,000
Jun 30, 2020	105,300,000
Mar 31, 2020	103,800,000
Dec 31, 2019	103,100,000
Sep 30, 2019	134,300,000
Jun 30, 2019	135,500,000
Mar 31, 2019	136,700,000
Dec 31, 2018	138,100,000
Sep 30, 2018	146,249,000
Jun 30, 2018	146,649,000
Mar 31, 2018	149,249,000
Dec 31, 2017	148,649,000
Sep 30, 2017	138,744,000
Jun 30, 2017	141,932,000
Mar 31, 2017	142,510,000
Dec 31, 2016	142,900,000
Sep 30, 2016	143,986,000
Jun 30, 2016	139,059,000
Mar 31, 2016	133,607,000
Dec 31, 2015	131,800,000
Sep 30, 2015	137,741,000
Jun 30, 2015	141,302,000
Mar 31, 2015	145,512,000
Dec 31, 2014	149,900,000
Sep 30, 2014	152,148,000
Jun 30, 2014	151,996,000
Mar 31, 2014	150,581,000
Dec 31, 2013	147,200,000
Sep 30, 2013	140,696,000
Jun 30, 2013	135,862,000
Mar 31, 2013	132,594,000
Dec 31, 2012	130,400,000
Sep 30, 2012	127,758,000
Jun 30, 2012	126,006,000
Mar 31, 2012	123,981,000
Dec 31, 2011	121,000,000
Sep 30, 2011	117,063,000
Jun 30, 2011	113,010,000
Mar 31, 2011	109,467,000
Dec 31, 2010	108,900,000
Sep 30, 2010	79,964,000
Jun 30, 2010	79,871,000
Mar 31, 2010	79,224,000
Dec 31, 2009	74,003,000
Sep 30, 2009	96,781,000
Jun 30, 2009	95,542,000
Mar 31, 2009	95,687,000
Dec 31, 2008	97,100,000
Sep 30, 2008	98,216,000
Jun 30, 2008	87,783,000
Mar 31, 2008	76,665,000
Dec 31, 2007	67,300,000
Sep 30, 2007	58,506,000
Jun 30, 2007	57,804,000
Mar 31, 2007	56,804,000
Dec 31, 2006	55,400,000
Sep 30, 2006	56,719,000
Jun 30, 2006	57,345,000
Mar 31, 2006	58,800,000
Dec 31, 2005	61,000,000
Sep 30, 2005	64,050,000
Jun 30, 2005	63,410,000
Mar 31, 2005	60,871,000
Dec 31, 2004	56,200,000
Sep 30, 2004	47,575,000
Jun 30, 2004	44,386,000
Mar 31, 2004	42,604,000
Dec 31, 2003	42,000,000
Sep 30, 2003	41,722,000
Jun 30, 2003	41,155,000
Mar 31, 2003	39,079,000
Dec 31, 2002	38,000,000
Sep 30, 2002	38,046,000
Jun 30, 2002	38,394,000
Mar 31, 2002	39,815,000
Dec 31, 2001	41,300,000
Sep 30, 2001	41,567,000